Suppr超能文献

米非司酮和米索前列醇与单独使用米索前列醇在尼日利亚宫内胎儿死亡妇女引产中的疗效和安全性比较:一项三盲随机对照试验。

A Comparison of the Efficacy and Safety of Mifepristone and Misoprostol Versus Misoprostol alone for Induction of Labour in Nigerian Women with Intrauterine Fetal Death: A Triple Blind Randomized Controlled Trial.

机构信息

Department of Obstetrics and Gynaecology, Delta State University Teaching Hospital, Oghara, Delta State, Nigeria.

Department of Obstetrics and Gynaecology, Asaba Specialist Hospital, Asaba, Delta State, Nigeria.

出版信息

Niger J Clin Pract. 2024 Feb 1;27(2):159-166. doi: 10.4103/njcp.njcp_786_22. Epub 2024 Feb 26.

Abstract

BACKGROUND

Intrauterine foetal death (IUFD) is an unpleasant pregnancy outcome and prompt delivery of the dead foetus is usually desired by mothers. Unfortunately, spontaneous labour and delivery may not occur early and prolonged retention of the dead foetus in utero is life-threatening. Many of the agents currently used for the induction of labour may result in a prolonged delivery process.

OBJECTIVES

To compare the efficacy and safety of mifepristone and misoprostol versus misoprostol alone for induction of labour in women with intrauterine foetal death.

MATERIALS AND METHODS

This was a triple-blind randomized controlled trial. Eighty women were randomized into two groups. The intervention group received a single oral dose of 200 mg mifepristone, followed by 6-hourly 50 μg misoprostol vaginal insertion, after 24-hour intervals. The control group received a placebo, followed by 6-hourly 50 μg misoprostol vaginal insertion, after 24-hour intervals. The primary outcome measure was the induction to delivery interval.

RESULTS

Maternal age, gestational age, parity and pre-induction bishop's score were comparable between the two groups. The mean induction to the delivery interval in the intervention group was significantly less in the intervention group than the control group (18.78 ± 6.51 hours versus 37.10 ± 10.10; P < 0.001). The total dose of misoprostol required for induction of labour; the need for oxytocin augmentation of labour; and the observed side effects of misoprostol were all significantly less in intervention group than control group (P < 0.001; P < 0.01; and P = 0.03, respectively).

CONCLUSION

The combination of mifepristone and misoprostol has greater efficacy and better safety profile than the use of misoprostol alone for induction of labour. This combination should be considered when induction of labour is indicated for IUFD.

摘要

背景

宫内胎儿死亡(IUFD)是一种不愉快的妊娠结局,母亲通常希望尽快分娩死胎。不幸的是,自发性分娩和分娩可能不会早期发生,而死胎在子宫内长时间滞留则有生命危险。目前用于引产的许多药物可能会导致分娩过程延长。

目的

比较米非司酮和米索前列醇联合与单独使用米索前列醇用于宫内胎儿死亡妇女引产的疗效和安全性。

材料和方法

这是一项三盲随机对照试验。80 名妇女被随机分为两组。干预组单次口服 200mg 米非司酮,24 小时后每 6 小时阴道插入 50μg 米索前列醇;对照组给予安慰剂,24 小时后每 6 小时阴道插入 50μg 米索前列醇。主要观察指标为引产至分娩的时间间隔。

结果

两组产妇年龄、胎龄、产次和诱导前毕晓普评分无差异。干预组的平均引产至分娩时间间隔明显短于对照组(18.78 ± 6.51 小时比 37.10 ± 10.10 小时;P < 0.001)。干预组所需米索前列醇总剂量、催产素引产需求以及米索前列醇观察到的副作用均明显少于对照组(P < 0.001;P < 0.01;P = 0.03)。

结论

米非司酮和米索前列醇联合应用的疗效优于单独使用米索前列醇,用于引产。在 IUFD 需要引产时应考虑这种联合用药。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验